Clinical Trial Update: Simvastatin Efficacy in ARID1A Mutated Advanced gastroESophageal Carcinoma Treated With Immunotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring simvastatin efficacy in ARID1A-mutated advanced gastroesophageal cancer treated with immunotherapy; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Cancer

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Advanced or Metastatic Gastrooesophageal Carcinoma | Phase 2 | Status: RECRUITING